Adial Pharmaceuticals
Price & Volume
Stats
See moreOpen | $0.86 |
Previous Close | $0.78 |
Day Range | $0.83-$1.18 |
52W Range | $0.57-$1.74 |
Market Cap | $5.1M |
Shares Short | 217,057 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.72 |
News
See moreYahoo Finance • 43 minutes ago
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds
Yahoo Finance • 2 months ago
Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04
Yahoo Finance • 2 months ago
Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
Yahoo Finance • 3 months ago
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
About
CEO | Mr. Cary John Claiborne MBA |
CFO | Mr. Vinay Shah A.C.A., M.B.A. |
Address | 4870 Sadler Road, Glen Allen, VA, United States, 23060 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |
